[Neurologic toxicity with low-dose methotrexate treatment]. 1990

S Lassoued, and M Caulier, and M Pages, and B Fournie, and A Fournie

UI MeSH Term Description Entries
D008297 Male Males
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009422 Nervous System Diseases Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. Neurologic Disorders,Nervous System Disorders,Neurological Disorders,Disease, Nervous System,Diseases, Nervous System,Disorder, Nervous System,Disorder, Neurologic,Disorder, Neurological,Disorders, Nervous System,Disorders, Neurologic,Disorders, Neurological,Nervous System Disease,Nervous System Disorder,Neurologic Disorder,Neurological Disorder
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D012216 Rheumatic Diseases Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement. Rheumatism,Disease, Rheumatic,Diseases, Rheumatic,Rheumatic Disease

Related Publications

S Lassoued, and M Caulier, and M Pages, and B Fournie, and A Fournie
April 2019, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
S Lassoued, and M Caulier, and M Pages, and B Fournie, and A Fournie
June 1989, Arthritis and rheumatism,
S Lassoued, and M Caulier, and M Pages, and B Fournie, and A Fournie
February 1992, The Medical journal of Australia,
S Lassoued, and M Caulier, and M Pages, and B Fournie, and A Fournie
March 1992, The Medical journal of Australia,
S Lassoued, and M Caulier, and M Pages, and B Fournie, and A Fournie
December 2022, Cureus,
S Lassoued, and M Caulier, and M Pages, and B Fournie, and A Fournie
July 2018, Proceedings (Baylor University. Medical Center),
S Lassoued, and M Caulier, and M Pages, and B Fournie, and A Fournie
March 1992, Presse medicale (Paris, France : 1983),
S Lassoued, and M Caulier, and M Pages, and B Fournie, and A Fournie
December 1985, The Journal of rheumatology. Supplement,
S Lassoued, and M Caulier, and M Pages, and B Fournie, and A Fournie
January 2024, Proceedings (Baylor University. Medical Center),
S Lassoued, and M Caulier, and M Pages, and B Fournie, and A Fournie
September 1985, Cancer,
Copied contents to your clipboard!